DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Comparitive Study of Two Misoprostol Regimen in Early Pregnancy Termination

Information source: Hormozgan University of Medical Sciences
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Termination

Intervention: Misoprostol 400 micrograms (Drug); Misoprostol 800 micrograms (Drug)

Phase: N/A

Status: Completed

Sponsored by: Hormozgan University of Medical Sciences

Summary

The aim of this study is to compare two misoprostol regimen in pregnancy termination.

Clinical Details

Official title: A Comparative Study of Vaginal Misoprostol Two Dosing Regimen for First Trimester Pregnancy Termination in Patients Admitted at Bandarabbas in Shariati Hospital in 2009

Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment

Primary outcome: Abortion

Secondary outcome:

Duration of abortion

Adverse Effects

Need for surgery

Detailed description: Studies on determining the optimal dosage for misoprostol in pregnancy termination are continuing and still there is no evidence for ideal misoprostol regimen for pregnancy termination. The aim of this study is to compare two misoprostol regimen in pregnancy termination.

Eligibility

Minimum age: N/A. Maximum age: N/A. Gender(s): Female.

Criteria:

Inclusion Criteria:

- All women who were candidates for early pregnancy termination because of fetal death

or other medical conditions

- Before 14th week of gestation calculated according LMP or first trimester sonography

Exclusion Criteria:

- Chorioamnionitis

- Hypersensitivity to prosstaglandins

- Past medical history of cardiovascular, kidney or liver or lung diseases

- Positive history for uterus pathologies

- suspicious to extra-uterus pregnancy

- sign and symptoms of uterus infection

- Molar pregnancy

Locations and Contacts

Hormozgan University of Medical Sciences, Bandar Abbas, Hormozgan 097145-3388, Iran, Islamic Republic of
Additional Information

Starting date: January 2012
Last updated: September 30, 2012

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017